|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/17 | |
| A61K 38/17 | |||
| A61P 7/00 | |||
| A61P 35/00 | |||
| A61P 35/02 | |||
| C07K 14/725 | |||
| C12N 5/0783 |
| (11) | Number of the document | 3307877 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16808492.9 |
| Date of filing the European patent application | 2016-06-12 | |
| (97) | Date of publication of the European application | 2018-04-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/037120 |
| Date | 2016-06-12 |
| (87) | Number | WO 2016/201394 |
| Date | 2016-12-15 |
| (30) | Number | Date | Country code |
| 201562175003 P | 2015-06-12 | US |
| (72) |
DROPULIC, Boro, US
ORENTAS, Rimas, US
SCHNEIDER, Dina, US
KRUEGER, Winfried, US
|
| (73) |
Lentigen Technology, Inc.,
910 Clopper Road, Suite 200S, Gaithersburg, MD 20878,
US
|
| (54) | METHOD TO TREAT CANCER WITH ENGINEERED T-CELLS |
| METHOD TO TREAT CANCER WITH ENGINEERED T-CELLS |